Back to Agenda
[V7-S5] More Advanced Approach of Medical Big Data - Part 2
Session Chair(s)
Hisashi Urushihara, DrPH
Professor, Faculty of Pharmacy, Department of Pharmacy
Keio University, Japan
Yuji Yamamoto, MD, MBA
Founder and CEO
MinaCare Co., Ltd., Japan
Medical big data have become indispensable in medicine development. Many people have been making decision by reference to information come from big data analysis. In this session, we will comprehensively review the advanced approach for big data utilization and future perspective with pioneering experts from Global as well as Japan. We will share advanced examples of clinical trial design and operations including randomized pragmatic trials, outcomes research and post-marketing safety assessments. The potential impact of GCP renovation will also be discussed.
Speaker(s)
TBC
Kotonari Aoki, MS
Chugai Pharmaceutical Co., Ltd., Japan
Head of Real World Data Science Dept. Drug Safety Div.
The Application of Big-data in Bayer Yakuhin
Shunichi Takahashi, PhD
Bayer Yakuhin, Ltd., Japan
Director, Head of Open Innovation Center Japan
Nancy A Dreyer, PhD, MPH, FISPE
Dreyer Strategies LLC, United States
Founder
Akiyuki Suzuki, MS
Pfizer Japan Inc., Japan
Senior Manager, Pharmacometrics Group, Clinical Pharmacology
Shinzo Hiroi, PhD, MPH, RPh, PMP
Shionogi & Co., Ltd., Japan
Head of Global Medical Affairs
Have an account?